[go: up one dir, main page]

DE69429365D1 - Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden - Google Patents

Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Info

Publication number
DE69429365D1
DE69429365D1 DE69429365T DE69429365T DE69429365D1 DE 69429365 D1 DE69429365 D1 DE 69429365D1 DE 69429365 T DE69429365 T DE 69429365T DE 69429365 T DE69429365 T DE 69429365T DE 69429365 D1 DE69429365 D1 DE 69429365D1
Authority
DE
Germany
Prior art keywords
dynorphine
tyr
analogs
des
inflammation composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69429365T
Other languages
English (en)
Inventor
Edward T Wei
Holly A Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Application granted granted Critical
Publication of DE69429365D1 publication Critical patent/DE69429365D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69429365T 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden Expired - Lifetime DE69429365D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/074,210 US5482930A (en) 1993-06-09 1993-06-09 Anti-inflammatory composition and method with des-Tyr dynorphin and analogues
PCT/US1994/006502 WO1994029337A1 (en) 1993-06-09 1994-06-09 Anti-inflammatory composition and method with des-tyr dynorphin and analogues

Publications (1)

Publication Number Publication Date
DE69429365D1 true DE69429365D1 (de) 2002-01-17

Family

ID=22118342

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69429365T Expired - Lifetime DE69429365D1 (de) 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Country Status (8)

Country Link
US (1) US5482930A (de)
EP (1) EP0751954B1 (de)
JP (1) JPH08511541A (de)
AT (1) ATE210149T1 (de)
AU (1) AU679241B2 (de)
CA (1) CA2164880A1 (de)
DE (1) DE69429365D1 (de)
WO (1) WO1994029337A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE276272T1 (de) * 1993-06-18 2004-10-15 Curative Tech Inc Entzündungshemmende peptide
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
US6228840B1 (en) * 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
CA2368670C (en) * 1999-03-26 2012-06-05 Chitra Suri Modulation of vascular permeability by means of tie2 receptor activators
US6706892B1 (en) * 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
CN1283317C (zh) * 2001-05-08 2006-11-08 东丽株式会社 类鸦片κ受体激动性化合物在制备治疗败血症的药物中的应用
US20050143300A1 (en) * 2003-10-10 2005-06-30 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050130897A1 (en) * 2003-12-11 2005-06-16 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
AU2011265315B2 (en) * 2004-05-12 2014-08-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
US8088787B2 (en) 2004-05-12 2012-01-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
BRPI0911945A2 (pt) 2008-05-13 2015-10-13 Clarassance Inc cc10 humana recombinante e suas composições para uso no tratamento de rinite nasal
MX2012004409A (es) 2009-10-15 2012-08-23 Clarassance Inc Proteina recombinante de humano cc10 para el tratamiento de la influenza.
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
CN116715726A (zh) * 2022-10-14 2023-09-08 深圳市维琪科技股份有限公司 合成肽及其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4361553A (en) * 1981-05-18 1982-11-30 Regents Of The University Of California Therapeutic uses of dynorphin
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4684624A (en) * 1983-12-22 1987-08-04 Yoshio Hosobuchi Method of treating cerebral ischemia
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
CA2137916A1 (en) * 1992-06-12 1993-12-23 Nancy M. Lee Des-tyr dynorphin analogues

Also Published As

Publication number Publication date
WO1994029337A1 (en) 1994-12-22
ATE210149T1 (de) 2001-12-15
CA2164880A1 (en) 1994-12-22
AU679241B2 (en) 1997-06-26
EP0751954A4 (de) 1998-06-03
EP0751954A1 (de) 1997-01-08
JPH08511541A (ja) 1996-12-03
AU7058394A (en) 1995-01-03
US5482930A (en) 1996-01-09
EP0751954B1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
PL319608A1 (en) Compositions for treating irds and ards, containing at least one glucocorticosteroid in a mixture with a pulmonic surfactant
GB9806632D0 (en) Peptide factor
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
ITMI912296A0 (it) Nuovi pregna 1,4-diene-3,20.dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
BG101232A (en) Bactericides
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
BG104059A (en) Diabetes treatment with rosiglytazone and insulin
ES8403884A1 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
EA199800819A1 (ru) Способ лечения биполярного расстройства
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
ZA815094B (en) Novel peptide
DE69433221D1 (de) Neues Chondrozytprotein
ES2094930T3 (es) Nueva proteina inhibidora de trombina aislada de garrapatas.
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
JPS5758630A (en) Interferon inducer
JPS51112864A (en) Polyurethane elastomer composition with improved dyeability
RU96100906A (ru) Способ радикального лечения первичного гипотиреоза
HUT45394A (en) Face-pack containing natrium-carboxi-methil-amilopectin

Legal Events

Date Code Title Description
8332 No legal effect for de